06.09.2022 - 08.09.2022Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 am - 5:15 pm
Temi della conferenza Hundreds of clinical trials using AAV are underway, with several hundred more in preclinical development. Given the sheer volume of studies in the pipeline, the need to administer high doses, the clinical holds placed on gene therapy trials, and regulatory bodies being increasingly stringent on the safety standards they require; it has never been more important to create and implement an AAV safety strategy that's fit for purpose!
Speakers: Anna Majowicz, Preclinical Immunology Lead, Spark Tx, Boris Gorovits, Vice President In Vitro Pharmacology and Bioanalysis, Sana Biotechnology, and more
Quote del Congresso Conference Only - Industry Pricing: USD 2999.00,
Conference + Workshop Day - Industry Pricing: USD 4297.00,
Conference Only - Academic Pricing: USD 2599.00,
Conference + Workshop Day - Academic Pricing: USD 3697.00
Contatto organizzatori 83 Great Titchfield Street W1W 6RH London United Kingdom